09/16/2024—AcePre LLC received a Notice of Award from National Heart, Lung, and Blood Institute (NHLBI) for the project entitled “Develop natural compound emodin as a novel therapy for calcific aortic valve disease”. This project is a collaborative effort between University of South Carolina and AcePre LLC. The total funding for this project is $299,953.00; the funding period is 09/17/2024-09/16/2025.

09/12/2024—AcePre LLC received a Notice of Award from National Institute on Aging (NIA) for the project entitled “Develop a novel strategy to deliver N-acetylcysteine for AD treatment”. This project entails collaboration between University of South Carolina and AcePre LLC. The total funding for this project is $499,441.00; the funding period is 09/15/2024-05/31/2025.